Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease.
Kidney Int
; 100(4): 881-893, 2021 10.
Article
en En
| MEDLINE
| ID: mdl-33964313
ABSTRACT
Outcomes relevant to treatment decision-making are inconsistently reported in trials involving glomerular disease. Here, we sought to establish a consensus-derived set of critically important outcomes designed to be reported in all future trials by using an online, international two-round Delphi survey in English. To develop this, patients with glomerular disease, caregivers and health professionals aged 18 years and older rated the importance of outcomes using a Likert scale and a Best-Worst scale. The absolute and relative importance was assessed and comments were analyzed thematically. Of 1198 participants who completed Round 1, 734 were patients/caregivers while 464 were health care professionals from 59 countries. Of 700 participants that completed Round 2, 412 were patients/caregivers and 288 were health care professionals. Need for dialysis or transplant, kidney function, death, cardiovascular disease, remission-relapse and life participation were the most important outcomes to patients/caregivers and health professionals. Patients/caregivers rated patient-reported outcomes higher while health care professionals rated hospitalization, death and remission/relapse higher. Four themes explained the reasons for their priorities confronting death and compounded suffering, focusing on specific targets in glomerular disease, preserving meaning in life, and fostering self-management. Thus, consistent reporting of these critically important outcomes in all trials involving glomerular disease is hoped to improve patient-centered decision-making.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Diálisis Renal
/
Cuidadores
Límite:
Adult
/
Humans
Idioma:
En
Revista:
Kidney Int
Año:
2021
Tipo del documento:
Article